ClinicalTrials.Veeva

Menu

Exercise Intervention in Primary Open-angle Glaucoma (EYE-FIT)

U

University of Granada (UGR)

Status

Not yet enrolling

Conditions

Glaucoma
Glaucoma, Open-Angle

Treatments

Other: Control
Behavioral: Exercise

Study type

Interventional

Funder types

Other

Identifiers

NCT05704777
PID2021-127505NA-I00 (Other Grant/Funding Number)

Details and patient eligibility

About

EYE-FIT is a randomized clinical trial with a two-arm parallel design aimed at assessing the impact of performing a structured and supervised physical training program on the different variables associated with glaucoma progression in pharmacologically treated primary open angle glaucoma patients. This intervention will include a supervised 24-weeks concurrent (endurance + resistance) training program comparing its influence to the standard care.

Full description

There are claims that more physically active individuals are less likely to glaucoma onset and progression. However, to date, there is not a single randomized controlled clinical trial assessing the impact of performing a structured and supervised physical training program on glaucoma progression. A randomized controlled clinical trial with a two-arm parallel design will be used to determine the chronic effects of a 24-weeks concurrent (endurance + resistance) training program in comparison to a control group (no training prescribed) on the ocular function and physical fitness of primary open angle glaucoma patients. Participants will be randomly divided in one of the two groups (experimental or control [wait-list]), while ocular function and physical fitness will be assessed before and after the intervention by researchers blinded to the group allocation of each participant. In addition, primary open angle glaucoma patients will be subdivided according to their medical treatment in two groups (prostaglandin analogues and combination of prostaglandin analogue and beta-blockers). Therefore, four groups will be considered in this clinical trial. The results of the EYE-FIT clinical trial will provide novel information on the influence of exercise on different markers of glaucoma, and may help to reduce the clinical, economic and social burden of this disease.

Enrollment

136 estimated patients

Sex

All

Ages

50 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Have an age between 50 and 70 years old
  • Primary open angle glaucoma diagnosis based on objective criteria (i.e., glaucomatous optic nerve head changes and visual field defects consistent with glaucoma, after the exclusion of other possible causes).
  • No have undergone any surgical intervention for glaucoma treatment
  • Be medically treated with prostaglandin analogues or with a combination of prostaglandin analogue and beta-blockers

Exclusion criteria

  • Have an scheduled surgery for the following 6 months
  • Have a sufficient level of mobility to perform supervised physical exercise
  • Suffer any disease that prevent the practice of physical exercise

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

136 participants in 2 patient groups

exercise
Experimental group
Description:
The intervention (endurance + resistance training) group will perform 48 training sessions (24 weeks, twice per week). In each session, they will perform the leg and arm cycling exercises during the first half of the session (15 minutes of leg cycling and 15 minutes of arm cycling) and resistance training exercises involving the lower-body (e.g., squat) and upper-body (e.g., a variety exercises performed against the resistance imposed by elastic bands) during the second half of the session.
Treatment:
Behavioral: Exercise
Other: Control
control
No Intervention group
Description:
The control group will not perform any supervised training program, and will follow standard care.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems